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Background: The Bacillus subtilis genome (BGM) vector is a novel cloning system based on the natural competence
that enables B. subtilis to import extracellular DNA fragments into the cell and incorporate the recombinogenic DNA
into the genome vector by homologous recombination. The BGM vector system has several attractive properties, such
as a megabase cloning capacity, stable propagation of cloned DNA inserts, and various modification strategies using
RecA-mediated homologous recombination. However, the endogenous RecA activity may cause undesirable
recombination, as has been observed in yeast artificial chromosome systems. In this study, we developed a novel
BGM vector system of an inducible recA expression BGM vector (iREX), in which the expression of recA can be
controlled by xylose in the medium.
Results: We constructed the iREX system by introducing the xylose-inducible recA expression cassette followed
by the targeted deletion of the endogenous recA. Western blot analysis showed that the expression of recA was
strictly controlled by xylose in the medium. In the absence of xylose, recA was not expressed in the iREX, and the
RecA-mediated recombination reactions were greatly suppressed. By contrast, the addition of xylose successfully
induced RecA expression, which enabled the iREX to exploit the same capacities of transformation and gene
modifications observed with the conventional BGM vector. In addition, an evaluation of the stability of the cloned
DNA insert demonstrated that the DNA fragments containing homologous sequences were more stably maintained in
the iREX by suppressing undesirable homologous recombination.
Conclusions: We developed a novel BGM vector with inducible recA expression system, iREX, which enables us to
manipulate large DNA fragments more stably than the conventional BGM vector by suppressing undesirable
recombination. In addition, we demonstrate that the iREX can be applied to handling the DNA, which has several
homologous sequences, such as multiple-reporter expression cassettes. Thus, the iREX expands the utility of the BGM
vector as a platform for engineering large DNA fragments.
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As genome analysis progresses, large genome regions
including noncoding DNA sequences are drawing
much attention. For studies of such regions, techno-
logical developments for handling large DNA fragments
are essential. Currently, there are several tools available* Correspondence: jhirota@bio.titech.ac.jp
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unless otherwise stated.for manipulating large DNA fragments, including bacterial
artificial chromosomes (BACs) [1] and yeast artificial
chromosomes (YACs) [2]. BACs are based on the F-factor
of Escherichia coli and can accommodate genomic DNA
inserts of up to 300 kb. BAC clones are easy to manipulate
and retrieve because of their plasmid form and the stabil-
ity of the cloned DNA. However, YACs can accommodate
larger DNA inserts than BACs. Although the cloning
capacity of YACs is extremely large, up to 2 Mb, YAC
DNA is difficult to purify because of its linear form,
and it suffers from insert chimerism [3,4].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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been developed as a novel cloning system for handling
large DNA fragments [5–7]. B. subtilis can import extra-
cellular DNA molecules into the cytoplasm in a single-
stranded form through its transformation machinery, and
the recombinogenic DNA is then integrated into the gen-
ome via RecA-mediated homologous recombination [8].
These sequential events are called “natural competence”.
Based on this natural competence, the B. subtilis genome
can serve as a vector in the BGM vector system. The
BGM vector system has several attractive properties,
including a large cloning capacity of over 3 Mb, the propa-
gation of cloned DNA fragments in a single copy per cell
and the facility of various modification strategies. To date,
various types of genomic DNA inserts, including cyano-
bacteria, Arabidopsis and mouse, have been cloned into
the BGM vector [5–7,9].
Recently, we have established complete gene modifica-
tion strategies, including targeted insertion, deletion, in-
version and fusion of DNA fragments, and we have
applied the BGM vector system to mouse transgenesis
[10]. Using the BGM vector system, we reconstructed a
252 kb genomic structure by fusing two mouse genomic
DNA fragments of 114 kb and 220 kb in the BGM vec-
tor and demonstrated the production of the transgenic
mouse carrying the reconstructed DNA. Thus, the BGM
vector system can now be recognized as a third platform
for transgenesis, in addition to the BAC and YAC systems.
Because of the flexibility of the modification strategy and
the megabase-scale cloning size, the BGM vector is a
promising tool for handling large DNA fragments.
However, the conventional BGM vector system has a
potential instability in the cloned DNA inserts. Various
gene manipulations in the BGM vector depend on the
RecA-mediated homologous recombination. Thus, the
endogenous RecA may cause undesirable recombination
if there are homologous sequences in the cloned DNA.
In fact, undesirable recombination, such as deletion due
to the endogenous recombinases, has been reported in
the YAC system, which also utilizes the endogenous
recombinases for gene modifications [4,11]. One method
for preventing such undesirable recombination is to in-
duce the expression of the recombinase specifically
during gene manipulations. In the BAC modification
strategy that uses the Red system, the recombination
proteins are inducible, and the host E. coli is recA-defi-
cient to stably maintain the BAC DNA [4,12–14]. Ac-
cordingly, undesirable recombination can be prevented
by the introduction of an inducible system into the
BGM vector system.
In this study, we developed an inducible recA expression
BGM vector (iREX) by introducing a xylose-inducible
recA expression cassette and deleting the endogenous
recA. Western blot analysis showed that the expressionof recA was strictly controlled by xylose in the medium.
In addition, we demonstrated that stability of the
cloned DNA is improved in the iREX in the absence of
xylose by suppressing the recA expression. Our novel
BGM vector, iREX, offers a new platform for stable
gene manipulation of large DNA fragments.
Results and discussion
Construction of the inducible recA expression BGM vector
(iREX)
The inducible recA expression BGM vector (iREX) was
constructed based on a BGM vector, BEST310, that was
designed for BAC cloning [7], by introducing the inducible
recA expression cassette followed by the targeted deletion
of the endogenous recA (Figure 1a). For the inducible ex-
pression of recA, we used the gene expression cassette pX
[15], in which the inducible promoter is regulated by xy-
lose, and this cassette was designed to integrate into the
amyE locus of B. subtilis. The inducible recA expression
cassette pX-recA was constructed by cloning the B.
subtilis recA into the BamHI site of pX and was inte-
grated into the amyE locus of BEST310 to generate
BEST310/pX-recA (Figure 1b). To delete the endogenous
recA from BEST310/pX-recA, the targeted replacement of
the endogenous recA with a tetracycline resistance gene
(tet) was performed using pCTP, in which tet was inserted
between the flanking sequences of the endogenous recA
designated cinA and pbpX (Figure 1c). The resulting re-
combinant construct was designated as the inducible recA
expression BGM vector, iREX. The insertion of pX-recA
and the replacement of the endogenous recA with tet were
confirmed by Southern blot analysis using an amyE probe
and a recA probe (Figure 1d and e).
Optimization of RecA inducing conditions in the iREX
To confirm the xylose-induced RecA expression, we first
performed Western blot analysis. In the absence of xylose,
there was no immunosignal for RecA detected from the
iREX, indicating that the expression of recA was strictly
repressed. In contrast, a signal for RecA was detected from
the iREX in the presence of xylose as well as from the
conventional BGM vector, BEST310. These results indi-
cate that the expression of recA was strictly controlled
by xylose (Figure 2a).
To optimize the conditions of RecA induction in the
iREX, we examined the effects of xylose concentration
and induction time on RecA activity. Because extracellu-
lar DNA can be integrated into the iREX genome by
RecA activity, we evaluated RecA activity in terms of
cloning efficiency. We measured cloning efficiency by
transforming the iREX with the pSHINE2122, which
contains the GFP gene and the erythromycin resistance
gene (Figure 2b). pSHINE2122 is constructed from
























































Figure 1 (See legend on next page.)
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Figure 1 Construction of the recA-inducible BGM vector system. (a) The BEST310 and iREX constructs that possess two antibiotic resistance
gene cassettes for BAC cloning: Pr-neo, a lambda Pr promoter fused to the neomycin resistance gene (neo), and cI-spc, which contains cI encoding the
CI repressor protein, which binds to the Pr promoter, fused to the spectinomycin resistance gene (spc). The closed and open arrows indicate the BAC
cloning site, and the red and blue lines indicate the pBR322 sequence. (b) The inducible recA expression cassette, pX-recA, was inserted at the
amyE locus of the BEST310 genome via homologous recombination. amyE is not essential for the viability of B. subtilis [15]. cat, chloramphenicol
acetyltransferase; H, HindIII; X, XhoI. (c) After introducing the pX-recA, the endogenous recA was replaced with the tetracycline resistance gene
(tet) via homologous recombination. X, XhoI. (d) Southern blot analysis using an amyE probe indicated the correct insertion of pX-recA. The
genomic DNA of the represented clones was digested with HindIII. The open arrowhead indicates the intact amyE in BEST310. The closed
arrowheads indicate 5’-amyE and 3’-amyE divided by the insertion of pX-recA. (e) Southern blot analysis using a recA probe indicated the
correct insertion of pCTP. The genomic DNA of the represented clones was digested with XhoI. The open arrowheads indicate the endogenous recA.
The closed arrowheads indicate the inducible recA derived from pX-recA.
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on GFP fluorescence and erythromycin resistance.
We first examined the induction time at a final xylose
concentration of 1.0% (Figure 2c). The maximum num-
ber of erythromycin-resistant colonies was obtained at
the induction time of 150 min. At this induction time,
we next determined the optimal xylose concentration
(Figure 2d). The number of erythromycin-resistant col-
onies plateaued at a final xylose concentration above
1.0%. Notably, there were no colonies in the absence of
xylose (Figure 2d and e), indicating that the expression
of recA was successfully repressed. The transformation
of the iREX was also confirmed by GFP fluorescence. All
the colonies that formed on the LB plates containing
erythromycin were fluorescent (Figure 2f ). The cloning
efficiency of the iREX was approximately 60% of that of
the original BGM vector, BEST310 (Figure 2d).
Cloning of the BAC insert into the iREX
One of the most attractive properties of the BGM vector
system is its capacity to clone very large DNA fragments.
To examine this important feature in the iREX, we con-
ducted one-step cloning of BAC DNA into the iREX.
The BAC clone, designated BAC1, carried a 114 kb
mouse genomic DNA fragment containing two class I
odorant receptor genes [10]. We transformed the iREX
with BAC1 to construct iREX/BAC1 (Figure 3a). Briefly,
the iREX is resistant to spectinomycin and sensitive to
neomycin because the CI repressor represses the Pr-neo
cassette. Once the BAC1 insert is cloned directly into
the iREX genome via homologous recombination, the
recombinants become resistant to neomycin and sensitive
to spectinomycin due to the replacement of the cI-spc cas-
sette with the BAC1 insert. Because two I-PpoI recogni-
tion sequences are introduced at the both ends of the
cloning site, the cloned BAC1 insert could be excised by
digesting the genomic DNA of the iREX recombinant with
I-PpoI and analyzed by contour-clamped homogeneous
electric field (CHEF) gel electrophoresis (Figure 3b). One
of 20 candidate clones (resistant to neomycin and sensitive
to spectinomycin) contained the BAC1 insert. The cloned
insert was confirmed by Southern blot analysis using theoriginal BAC1 clone as a probe (Figure 3c). The digestion
patterns of iREX/BAC1 were identical to those of the
original BAC clone, except for the fragments derived
from the ends of the insert. Thus, the iREX was able to
clone a giant DNA sequence of over 100 kb, similar to
the conventional BGM vector system.
Evaluation of the stability of the cloned DNA in the iREX
Previously, we demonstrated that the cloned BAC insert
of the BGM vector could be inverted via homologous re-
combination between two homologous sequences in the
reverse direction [10]. This inversion simply occurs dur-
ing incubation due to the activity of endogenous RecA.
Thus, the undesirable recombination of the cloned in-
sert, such as by inversion, deletion, or rearrangement,
can occur in the conventional BGM vector if the cloned
insert has several homologous sequences. Because the
expression of recA is tightly controlled in the iREX, it is
possible that the iREX system can minimize such un-
necessary recombination.
To examine this, we first evaluated the stability of the
cloned insert in terms of homologous recombination-
mediated inversion using the tet-inversion cassette system
[10]. Because the tet-inversion cassette system is
dependent on the construction of the tet, we deleted tet in
iREX/BAC1 by replacing tet with the cI-bsr cassette, which
consisted of the CI repressor gene and the blasticidin S re-
sistance gene. Then, two incomplete fragments of the
tetracycline resistance gene, te (5’ end) and et (3’ end),
which shared an overlapping region of approximately
1.1 kb, were inserted at the ends of the BAC1 sequences
of iREX/BAC1 and of BEST310/BAC1. The recombin-
ation between the overlapping homologous sequences be-
tween the incomplete tet fragments resulted in the
inversion of the cloned inserts as well as the acquisition of
tetracycline resistance because of the formation of the
complete tet (Figure 4a). Overnight cultures of iREX/
BAC1 or BEST310/BAC1 with the tet-inversion cassette
were spread on LB plates containing tetracycline, and the
numbers of tetracycline-resistant colonies were counted.
Notably, many tetracycline-resistant colonies were formed


































































































Figure 2 Western blot analysis and optimization of RecA induction. (a) Western blot analysis with an anti-RecA antibody indicated the expression
of RecA in the presence of xylose. Remarkably, expression of RecA in the absence of xylose was strictly repressed. BEST310/ΔrecA, that was constructed
by replacing the endogenous recA of BEST310 with tet of pCTP, was used as a negative control. (b) Schematic diagram of the cloning procedure. erm,
erythromycin resistance gene; EmS, erythromycin sensitive; EmR, erythromycin resistant. (c) Numbers of erythromycin-resistant colonies under various
induction times after addition of 1.0% xylose. Error bars, s.d. n= 3. (d) Numbers of erythromycin-resistant colonies under various xylose concentrations
at 150 min induction. Error bars, s.d. n = 3. (e) Erythromycin-resistant recombinants were obtained only in the presence of xylose. The picture of xylose
(+) is representative plate at a final xylose concentration of 1.0% at the induction time of 150 min. (f) All colonies formed on LB plates containing
erythromycin were fluorescent due to their GFP gene.




































Figure 3 Cloning of BAC1 into the iREX. (a) One-step cloning of BAC1 into the iREX. NmS, neomycin sensitive; NmR, neomycin resistant; SpcS,
spectinomycin sensitive; SpcR, spectinomycin resistant; I, I-PpoI recognition sequence. (b) iREX/BAC1 was digested with I-PpoI followed by CHEF
gel electrophoresis. The BAC1 insert is indicated as an open arrowhead, and the BGM vector is indicated as a closed arrowhead. A lambda DNA
concatemer was used as a size marker in lane M. (c) Original BAC1 and genomic DNA of the iREX recombinant were digested with EcoRI or
HindIII and hybridized with the original BAC1 clone as a probe. Band patterns identical to the original BAC1 clones were confirmed in the iREX
recombinant, except for the bands derived from the BAC end sequences. The closed arrowhead indicates a BAC1-specific signal, and the open
arrowheads indicate BGM-specific signals. In lane M, lambda/HindIII fragments were used as a size marker.
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there were few colonies in the iREX system in the absence
of xylose, indicating that the cloned DNA insert was main-
tained much more stably in the iREX system than in the
conventional BGM vector system (Figure 4b and c). The
inversion of the inserts was confirmed by Southern blot
analysis using a tet probe (Figure 4d and e).
A small number of colonies formed in the iREX system
without xylose, which indicated that a residual recombin-
ase activity remained in the iREX, most likely due to leaky
expression of recA or other recombinase activity. To
examine these possibilities, we constructed the recA-defi-
cient strain, and performed the same experiment again.Because no tetracycline-resistant colonies were formed
(data not shown), the small number of tetracycline-
resistant colonies in the iREX system in the absence of
xylose can be attributed to the leaky expression of recA.
Application of the iREX to construct a transgene with
multiple reporters
As shown in Figure 4, the existence of the homologous
sequences in the cloned insert caused undesirable DNA
rearrangement in the conventional BGM vector. To moni-
tor the expression of multiple genes simultaneously, we
often use the strategy of inserting multiple reporters using
IRES bicistronic expression cassettes. It is possible that the























































































Figure 4 Evaluation of the stability of the cloned DNA using inversion. (a) Schematic diagram of the evaluation of the cloned DNA stability
using inversion. TetS, tetracycline sensitive; TetR, tetracycline resistant. (b) Numbers of tetracycline-resistant colonies in the BEST310 system and
the iREX system. Error bars, s.d. n = 3. (c) Many tetracycline-resistant recombinants were observed in the BEST310 system. In the iREX system, the
same results were obtained in the presence of xylose because of the induced RecA. In contrast, few colonies were observed using the iREX in the
absence of xylose. This result indicates that the cloned DNA insert of the iREX is stably maintained due to the strong repression of recA. (d and e)
Southern blot analysis using a tet probe revealed changes in the sizes of the signals, indicating the inversion of the BAC1 insert. The genomic
DNA of the represented clones was digested with BamHI. In lane M, lambda/HindIII fragments were used as a size marker.
































































































Figure 5 (See legend on next page.)
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Figure 5 Stable gene manipulation in the iREX by preventing the deletion. (a) Schematic diagram of the insertion of IRES-tauEGFP-cI-spc
and IRES-tauLacZ into MOR42-3 and MOR42-2, respectively, and the assumed deletion at the IRES-tau sequences. (b) The signal derived from the
deletion was observed in BEST310/BAC1-GL (open arrowhead). The same result was obtained in iREX/BAC1-GL in the presence of xylose because
of the induced RecA. In contrast, the signal derived from the deletion was not observed for iREX/BAC1-GL in the absence of xylose due to the
strong repression of recA. The closed arrowheads indicate the signals derived from the intact inserts of BEST310/BAC1-GL and iREX/BAC1-GL.
BEST310/BAC1-GL-deletion, which was screened from BEST310/BAC1-GL culture by neomycin resistance and spectinomycin sensitivity, was used
as a control of deletion. The BGM vector is indicated as a closed arrow. (c) The proportions of the spectinomycin-resistant clones containing two
IRES-tau sequences were 69% and 73% in the BEST310/BAC1-GL and iREX/BAC1-GL with xylose, respectively. In contrast, the proportion of the
spectinomycin-resistant clones was 93% in the iREX/BAC1-GL without xylose. Error bars, s.d. n = 3.
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recombination and lead to the instability of the recombi-
nants. To examine this possibility, i.e., unwanted recom-
bination between two reporter sequences, we constructed
transgenes with two bicistronic cassettes in both the iREX
and the conventional BGM vector.
We inserted IRES-tauEGFP-cI-spc and IRES-tauLacZ
3 bp downstream of the stop codon of the class I odor-
ant receptor genes of MOR42-3 and MOR42-2 in iREX/
BAC1 and BEST310/BAC1 to generate iREX/BAC1-GL
and BEST310/BAC1-GL, respectively (Figure 5a). Fusion
of the microtubule-associated protein tau with the re-
porter protein enables the visualization of the axonal
projections of neurons expressing the reporter gene.
Both iREX/BAC1-GL and BEST310/BAC1-GL contain
two homologous sequences of IRES-tau. First, we spread
these recombinants on LB plates containing spectino-
mycin, and then we inoculated the formed colonies into
liquid spectinomycin-free LB medium. The genomic
DNA of the overnight cultures was digested with I-PpoI
and analyzed using CHEF gel electrophoresis to examine
the digestion pattern derived from the deletion. In
BEST310/BAC1-GL, there was an additional signal, indi-
cating that the deletion derived from the RecA activity
had occurred (Figure 5b). The same result was obtained
in the iREX/BAC1-GL with xylose due to the induced
RecA. By contrast, no deletion signal was shown by the
iREX/BAC1-GL in the absence of xylose. To examine
the deletion event further, we quantified the event by es-
timating the proportions of the spectinomycin-resistant
clones containing two homologous sequences of IRES-
tau. The proportions of the intact clones were 69% and
73% in the BEST310/BAC1-GL and iREX/BAC1-GL
with xylose, respectively (Figure 5c). On the other hand,
the proportion of the intact clones was 93% in the iREX/
BAC1-GL without xylose. These results indicate that the
iREX can stably maintain the cloned DNA insert by pre-
venting deletion at two homologous sequences.
Accordingly, the iREX is capable of handling large DNA
fragments more stably than the conventional BGM vector
system. In the YAC system, undesirable rearrangements
also occur due to endogenous yeast recombination activity
[4,11]. Thus, prevention of such undesirable rearrange-
ments is necessary for the precise manipulation of largeDNA fragments. In our previous study, the next gener-
ation DNA sequencing analysis of modified and recon-
structed BGM clones confirmed that there were no
mutations in cloned inserts with repetitive sequences,
such as SINE and LINE [10]. However, in our current
study, we observed deletions at the IRES-tau sequences
during incubation only with the conventional BGM vector
(Figure 5), suggesting that the existence of a certain hom-
ologous sequence can cause DNA rearrangement but that
such rearrangements can be suppressed in the iREX.
Conclusions
We developed a novel BGM vector, iREX, in which a
xylose-inducible recA system was introduced. Western
blot analysis and an evaluation of the stability of the
cloned DNA insert demonstrate the considerable im-
provements in the stability of the cloned inserts that were
achieved using the iREX due to the strict control of the
expression of recA. The iREX can offer gene manipulation
that is more stable than the conventional BGM vector and
expand the utility of the BGM vector as a platform for en-
gineering large DNA fragments.
Methods
Strains
The B. subtilis strain of the BGM vector, BEST310 [7], was
used and modified to develop the inducible recA expres-
sion BGM vector (iREX) system. B. subtilis 168 trpC2 [16]
was also used for the PCR template to clone the recA and
flanking sequences of the recA (cinA and pbpX).
Construction of the inducible recA expression BGM vector
(iREX)
To generate the iREX, we used the xylose-inducible gene
expression cassette pX, which consists of the repressor
gene xylR and the xylA promoter derived from the Ba-
cillus megaterium operon for xylose utilization, followed
by a multi-cloning site [15]. The recA was amplified by
PCR (PrimeSTAR HS DNA polymerase, TaKaRa) using
the genomic DNA of B. subtilis 168 trpC2 as the tem-
plate, and the PCR fragment was then cloned into the
BamHI site of pX to construct pX-recA. The inducible
recA expression cassette is flanked by 5’- and 3’- amyE;
thus, the cassette can be inserted into the amyE locus of
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pX-recA was digested with ScaI (TaKaRa), and linearized
pX-recA was introduced into the BEST310 genome via
transformation. The recombinants were screened using
chloramphenicol to obtain BEST310/pX-recA. To con-
struct the endogenous recA deletion cassette, the flanking
sequences of the endogenous recA, designated cinA
(1.4 kb) and pbpX (1.4 kb), were amplified by PCR
(PrimeSTAR HS DNA polymerase, TaKaRa) using the
genomic DNA of B. subtilis 168 as the template. The
PCR fragments were then cloned into the SalI-EcoRI
site and the BamHI-SacII site of pBluescript II SK(+)
to construct pCP. After these steps, an EcoRI-BamHI
fragment of the tetracycline resistance gene from
pBEST307 [17] was cloned into the EcoRI-BamHI site
of pCP to generate pCTP. pCTP was digested with
XhoI (TaKaRa), and the linearized pCTP was used for
transformation to delete the endogenous recA of
BEST310/pX-recA. The recombinants were screened
using tetracycline to obtain the iREX. Primer se-
quences and PCR conditions are summarized in Add-
itional file 1. The accuracy of the sequences generated
by PCR was confirmed by DNA sequencing.
Southern blot analysis of the BGM clones
Genomic DNA from the BGM clones was prepared
using the liquid isolation method [18]. The genomic
DNA was digested with HindIII, XhoI, EcoRI or BamHI
(TaKaRa). The digested DNA was separated by CHEF
gel electrophoresis followed by Southern blot analysis as
described previously [10].
Western blot analysis of RecA
The whole cell lysates of B. subtilis, BEST310 and the
iREX were used for protein samples for the Western blot
analysis. The competent cells of BEST310 were prepared
as described elsewhere [18]. In the case of the iREX, xylose
was added to the TF-II medium to a final concentration of
1% followed by 60 min incubation. The cells of BEST310
and the iREX were collected by centrifugation (1500 × g)
at 4°C for 15 min and were washed twice by resuspending
the pellet with 1 ml of PBS the first time and 0.7 ml the
second time, followed by centrifugation (9500 × g) at 4°C
for 2 min. After the final centrifugation, the cells were
resuspended in PBS containing protease inhibitors
(1 mM PMSF, 1.4 μM Pepstatin A, 0.3 μM Aprotinin,
and 1 μM Leupeptin) in a final volume of 30 μL to give
an OD600 of 50. The cells were lysed by repeated cycles
of freezing and thawing (5 times). An equal volume of
2× SDS sample buffer [0.1 M Tris, 4.5% (wt/vol) SDS,
20% (vol/vol) Glycerol, 0.2% (vol/vol) Bromophenol
blue] containing 12% (vol/vol) β-mercaptoethanol was
added to the cell lysate, and aliquots were used for
samples. Samples were heated for 5 min at 95°C beforeloading. Proteins were electrophoretically separated by
SDS/PAGE on 12.5% (wt/vol) polyacrylamide gels and
5% (wt/vol) stacking gels and then transferred to nitrocel-
lulose membranes (GE Healthcare). Each membrane was
blocked in 5% (wt/vol) skimmed milk in TBS containing
0.05% (vol/vol) Tween 20, washed three times in TBST for
10 min each and then reacted with anti-RecA polyclonal
antibody (Abnova, PAB15568) overnight at 4°C. Anti-
RecA polyclonal antibodies were diluted 1:1,000 into
1% (wt/vol) skimmed milk in TBS-0.05% (vol/vol)
Tween 20. Primary antibodies were detected using
peroxidase-conjugated goat anti-rabbit IgG (GE Health-
care) with the ECL Western Blotting Detection System
(GE Healthcare) and the Molecular Imager ChemiDoc
XRS (Bio-Rad).Optimization of RecA induction in the iREX
The preparation of competent cells and the transform-
ation of B. subtilis/BGM vectors were performed as de-
scribed elsewhere [18]. To optimize the concentration of
xylose, we added xylose to the growth medium to final
concentrations of 0 to 3.0%. Briefly, xylose was added to
the TF-II medium followed by 60 min incubation. When
the xylose induction time was over 60 min, xylose was
added to the TF-D medium again, followed by additional
incubation. Transformation was performed at the end of
the xylose induction by the addition of 500 ng of the
pSHINE2122, which contains the GFP gene and the
erythromycin resistance gene. pSHINE2122 harbors the
erythromycin resistance gene instead of the chloram-
phenicol resistance gene found in pSHINE2121 [19,20].
The recombinants were screened for GFP fluorescence
and erythromycin resistance. The colony number of the
recombinants is an index of the induction efficiency.
One-step transfer of the BAC insert into the iREX
The transfer of the BAC clone into the iREX was per-
formed as described elsewhere except for the xylose-
induction step [7,10]. The BAC clone, RP24-392H7
(designated BAC1), was purchased from the Children’s
Hospital Oakland Research Institute. The BAC1 DNA
was prepared by the alkaline lysis method and subse-
quent equilibrium centrifugation in a CsCl-ethidium
bromide gradient [5]. The iREX was transformed with
the purified BAC1 DNA in the presence of 1.0% xylose
at 150 min induction.
I-PpoI/CHEF analysis
The cloned BAC1 insert in iREX/BAC1 was analyzed by
I-PpoI digestion followed by CHEF electrophoresis as
described previously [10]. The inserts of BEST310/
BAC1-GL and iREX/BAC1-GL were also analyzed by
I-PpoI/CHEF analysis.
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To replace the tet in iREX/BAC1 with another antibiotic
resistance gene, a cI-bsr cassette was inserted into the
EcoRI site of pCP to generate pCCBP. pCCBP was linear-
ized with XhoI (TaKaRa) and used for transformation to
replace the tet of iREX/BAC1 with cI-bsr. After this modi-
fication, the 5’ side of the tet (te) and the 3’ side of the tet
(et), which shared an overlapping region of approximately
1.1 kb, designated e, were sequentially inserted into both
edges of the BAC1 insert of iREX/BAC1. The recombi-
nants, which had both te and et, were screened using
erythromycin and phleomycin. Similar constructs were
prepared using the conventional BGM vector, BEST310,
which includes the BAC1 insert (BEST310/BAC1). The
recombinants of iREX/BAC1 were cultivated in LB broth
at 37°C for 16 hours with or without xylose. The recom-
binant BEST310/BAC1 was also cultivated in LB broth at
37°C for 16 hours. A portion of the culture was spread
onto an LB plate containing tetracycline. The inoculum
was fixed according to the following formula: Inoculum
(μL) = 100 / OD600.
Construction of multiple-reporter transgenes
To construct iREX/BAC1-GL and BEST310/BAC1-GL,
the cI-spc cassette was inserted 3 bp downstream of the
stop codon of MOR42-2 in iREX/BAC1 and BEST310/
BAC1, followed by the replacement of the cI-spc cassette
with the IRES-tauLacZ cassette and the insertion of the
IRES-tauEGFP-cI-spc cassette 3 bp downstream of the stop
codon of MOR42-3. To construct the IRES-tauLacZ cas-
sette, the EcoRI site of the coding region of LacZ in the
iTLZ-ACNF plasmid [21] was mutated by PCR mutagen-
esis, and an EcoRI-SpeI fragment of the IRES-tauLacZ cas-
sette from the iTLZ-ACNF plasmid was inserted into the
pT1 vector [10], whose NdeI site was deleted to construct
pT1-iTLZ. The 1.0 kb left (L) and right 1.0 kb (R) arms for
the targeted insertion of cI-spc into MOR42-2 and the re-
placement of cI-spc with IRES-tauLacZ were prepared by
PCR and contained sequences that were homologous to
the upstream and downstream MOR42-2 insertion sites,
respectively. The L arm was first cloned into the SalI-
EcoRI site of pT1-iTLZ, and the R arm was then cloned
into the SpeI-SphI site to generate the IRES-tauLacZ cas-
sette. The cI-spc cassette was constructed by inserting an
EcoRI-SpeI fragment of cI-spc between the L arm and R
arm. Primer sequences and PCR conditions are summa-
rized in Additional file 1. The IRES-tauEGFP-cI-spc
cassette was constructed previously [10].
Estimation of the proportion of the spectinomycin
resistant clones containing multiple reporter sequences
The iREX/BAC1-GL was cultivated in LB broth at 37°C
for 16 hours with or without xylose. The BEST310/BAC1-GL was also cultivated as a control in LB broth at
37°C for 16 hours. A portion of the culture was spread
onto an LB plate containing spectinomycin or neomycin.
The spectinomycin-resistant colonies and neomycin-
resistant colonies were counted and the proportion of the
spectinomycin resistant colonies was calculated according
to the following formula: (number of spectinomycin-
resistant colony)/(number of spectinomycin-resistant col-
ony + number of neomycin-resistant colony) × 100.
Additional file
Additional file 1: Primer sequences and PCR conditions. This file
contains information of all primer sequences and PCR conditions used in
this study for cloning and constructing homology arms, cassettes.
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